Literature DB >> 19103204

Physiologic and cardiac roles of beta-arrestins.

Priyesh A Patel1, Douglas G Tilley, Howard A Rockman.   

Abstract

Beta-arrestin1 and beta-arrestin2 were initially identified by sequence homology to visual arrestins and by their ability to bind to and inactivate signaling of the beta-2-adrenergic receptor in a process known as desensitization. While the role of beta-arrestins in desensitization has been known for some time, more recent evidence has revealed that beta-arrestins are multifunctional scaffolding proteins that are involved in numerous aspects of G protein-coupled receptor (GPCR) signaling. Interestingly, exciting new data shows that beta-arrestins can mediate signaling in their own right independent of classical second messenger mediated signaling, and that this beta-arrestin-mediated signaling may be cardioprotective. Identifying novel ligands for GPCRs that can block G protein-mediated signaling while simultaneously promoting beta-arrestin-mediated signaling could provide powerful new therapies for cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103204     DOI: 10.1016/j.yjmcc.2008.11.015

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  22 in total

Review 1.  New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors:  J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.

Authors:  Mauro Sbroggiò; Daniela Carnevale; Alessandro Bertero; Giuseppe Cifelli; Emanuele De Blasio; Giada Mascio; Emilio Hirsch; Wadie F Bahou; Emilia Turco; Lorenzo Silengo; Mara Brancaccio; Giuseppe Lembo; Guido Tarone
Journal:  Cardiovasc Res       Date:  2011-04-14       Impact factor: 10.787

3.  Calcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart.

Authors:  Junhui Sun; Elizabeth Murphy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-10       Impact factor: 4.733

4.  β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling.

Authors:  Jinju Li; Jennifer L Philip; Xianyao Xu; Tiju Theccanat; M Abdur Razzaque; Shahab A Akhter
Journal:  J Mol Cell Cardiol       Date:  2014-08-15       Impact factor: 5.000

5.  Differential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptor.

Authors:  David M Zuckerman; Stuart W Hicks; Guillaume Charron; Howard C Hang; Carolyn E Machamer
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

Review 6.  Protease-activated receptors and myocardial infarction.

Authors:  Silvio Antoniak; Rafal Pawlinski; Nigel Mackman
Journal:  IUBMB Life       Date:  2011-03-24       Impact factor: 3.885

7.  Arresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4.

Authors:  Arun K Shukla; Jihee Kim; Seungkirl Ahn; Kunhong Xiao; Sudha K Shenoy; Wolfgang Liedtke; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

8.  Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4.

Authors:  Tiju Theccanat; Jennifer L Philip; Abdur M Razzaque; Nicholas Ludmer; Jinju Li; Xianyao Xu; Shahab A Akhter
Journal:  Cell Signal       Date:  2015-11-27       Impact factor: 4.315

9.  Differences in the control of basal L-type Ca(2+) current by the cyclic AMP signaling cascade in frog, rat, and human cardiac myocytes.

Authors:  Rimantas Treinys; Andrius Bogdelis; Lina Rimkutė; Jonas Jurevičius; Vytenis Arvydas Skeberdis
Journal:  J Physiol Sci       Date:  2015-12-16       Impact factor: 2.781

Review 10.  Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.

Authors:  Priyesh A Patel; Adrian F Hernandez
Journal:  Eur J Heart Fail       Date:  2013-05-02       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.